Kazia Therapeutics Ltd ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2023-12-31 |
|---|---|---|
Revenue | $2,480 | $ |
Gross Profit | 2,480 | |
EBITDA | -18,644 | -7,948 |
EBIT | -19,578 | -8,883 |
Net Income | -17,954 | -8,823 |
Net Change In Cash | 2,480 | |
Free Cash Flow | -3,246 | -6,334 |
Cash | 1,657 | 3,562 |
Basic Shares | 575 | 479 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $2,308 | $ | $ | $15,182 |
Gross Profit | 2,308 | 15,182 | ||
EBITDA | -26,766 | -22,277 | -23,514 | -5,112 |
EBIT | -28,635 | -24,146 | -25,384 | -6,377 |
Net Income | -26,778 | -20,465 | -24,647 | -8,421 |
Net Change In Cash | 2,308 | 15,182 | ||
Free Cash Flow | -9,581 | -15,156 | -22,761 | -9,110 |
Cash | 1,657 | 5,241 | 7,361 | 27,586 |
Basic Shares | 479 | 368 | 265 | 235 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$12.30 |
2024-09-30 | -$31.22 |
2021-03-31 | -$0.006 |
2020-12-31 | -$0.006 |
